Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$76.22 - $98.51 $84,985 - $109,838
-1,115 Closed
0 $0
Q3 2022

May 28, 2024

SELL
$82.16 - $96.94 $4,929 - $5,816
-60 Closed
0 $0
Q1 2022

May 28, 2024

BUY
$74.28 - $92.69 $4,456 - $5,561
60 New
60 $4,000
Q1 2021

May 20, 2021

BUY
$74.73 - $90.69 $4,483 - $5,441
60 Added 5.69%
1,115 $84,000
Q3 2020

Nov 03, 2020

BUY
$71.87 - $131.03 $75,822 - $138,236
1,055 New
1,055 $80,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Rockbridge Investment Management, Lcc Portfolio

Follow Rockbridge Investment Management, Lcc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockbridge Investment Management, Lcc, based on Form 13F filings with the SEC.

News

Stay updated on Rockbridge Investment Management, Lcc with notifications on news.